Skip to content

H2020FP7HORIZONEDF

Klinikum der Technischen Universität München (Tum Klinikum)

Country
DEGermany
Defence projects
1
Projects, all programmes
116
As coordinator
41
EU contribution (CORDIS)
EUR 83,042,333
Active
2008 to 2026

Projects

116 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
MINDVIEWMultimodal Imaging of Neurological DisordersFP72013ParticipantEUR 324,200
CBM-INNATERegulation and Function of CARD9 / BCL10 / MALT1 Signalosomes in Innate Immunity and InflammationFP72013CoordinatorEUR 2,440,200
MAGNETOGENETICSReverse engineering the vertebrate molecular machinery for magnetic biomineralisationFP72013CoordinatorEUR 649,598
FI-STARFuture Internet Social and Technological Alignment ResearchFP72013ParticipantEUR 599,890
SIFEMSemantic Infostructure interlinking an open source Finite Element tool and libraries with a model repository for the multi-scale Modelling and 3d visualization of the inner-earFP72013ParticipantEUR 105,200
OPTIMEXOptimizing Exercise Training in Prevention and Treatment of Diastolic Heart FailureFP72013ParticipantEUR 536,600
AGORAATMP GMP Open Access Research Alliance - AGORAFP72013ParticipantEUR 74,040
MEETMitochondrial European Educational TrainingFP72013ParticipantEUR 247,633
BBMRI-LPCBBMRI - Large Prospective CohortsFP72013ParticipantEUR 443,656
EU-CERT-ICDComparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUropeFP72013ParticipantEUR 314,916
CAM-PACIntegrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic CancerFP72013ParticipantEUR 260,863
BIOMEDBRIDGESBuilding data bridges between biological and medical infrastructures in EuropeFP72012ParticipantEUR 821,105
MUMIMultimodal Molecular ImagingFP72012CoordinatorEUR 2,238,617
CELLEUROPEImproving HSCT By Validation Of Biomarkers & Development Of Novel Cellular TherapiesFP72012ParticipantEUR 190,801
ABIRISKAnti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the riskFP72012ParticipantEUR 658,000
MIP-DILIMechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver InjuryFP72012ParticipantEUR 837,312
NANODEMNANOphotonic DEvice for Multiple therapeutic drug monitoringFP72012ParticipantEUR 366,800
TESISTowards an Embodied Science of InterSubjectivityFP72011ParticipantEUR 446,230
BIOHYBRIDBiohybrid templates for peripheral nerve regenerationFP72011ParticipantEUR 7,200
TIRCONTreat Iron-Related Childhood-Onset NeurodegenerationFP72011ParticipantEUR 844,340

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.